UNIGE document Scientific Article
previous document  unige:25403  next document
add to browser collection

Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques

Published in Revue médicale suisse. 2011, vol. 7, no. 278, p. 154-8
Abstract Two new glycoconjugate vaccines protecting against invasive diseases caused by 13 pneumococcal serotypes or 4 meningococcal serogroups will soon be available in Switzerland. They offer real new perspectives for young children, and for high-risk group adults. As their development is recent, the data one may wish to have is not yet fully available for each age and disease categories. This article attempts to delineate the interest of these new glycoconjugate vaccines and their limits. The additional information (and the answers to numerous expected questions) will be distributed to the 4300 subscribers of InfoVac (www.infovac. ch), which just celebrated its 10th birthday.
Keywords HumansMeningococcal Infections/prevention & controlMeningococcal Vaccines/therapeutic usePneumococcal Infections/prevention & controlPneumococcal Vaccines/therapeutic useVaccines, Conjugate
PMID: 21400950
Full text
Article (Published version) (550 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch
Research group Centre de Vaccinologie et d'Immunologie néonatale (177)
(ISO format)
SIEGRIST, Claire-Anne. Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques. In: Revue médicale suisse, 2011, vol. 7, n° 278, p. 154-8. https://archive-ouverte.unige.ch/unige:25403

214 hits

1 download


Deposited on : 2013-01-11

Export document
Format :
Citation style :